Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Direxion Daily S&P Biotech Bull 3X Shares (LABU)

Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
Today|||52-Week Range
LABU Short Term Capital Gains Dividend: LABU began trading ex-dividend on 12/13/17. A $0.1326 short term capital gains dividend will be paid to shareholders of record as of 12/14/17.

Investment Objective

The investment seeks daily investment results- before fees and expenses- of 300% of the daily performance of the S&P Biotechnology Select Industry Index ("index"). The fund- under normal circumstances- invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments that provide daily leveraged exposure to the index and/or exchange-traded funds ("ETFs") that track the index. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.

No recent news for Direxion Daily S&P Biotech Bull 3X Shares.


1 month+5.01% 3 years--
3 months-9.53% 5 years--
1 year+94.06% Since inception-27.55%
Data through 12/16/2017

Quote Details

Previous close$69.95
Open day’s range67.26 – 71.37
Net asset value (NAV)69.83 (12/15/2017)
Daily volume979,039
Average volume (3 months)1,160,204
Data as of 6:30pm ET, 12/15/2017

Peer Comparisonvs. Trading--leveraged equity ETFs

Performance 5-yr return--+16.48%
Expense Gross exp ratio1.11%2.03%
Risk 5 year sharpe ratio----
Net assets$478.3M$96.0M
Average market cap$4.6B--
Average P/E----
Dividend / Share--0.30%


No competitors data available.


Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
XBI SPDR® S&P Biotech ETF21.49%
-- 7.20%
-- 5.94%
-- 5.88%
-- 4.28%
-- 0.97%